HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gimme Some Skin: New German Dermatology Products From Engelhard, Medice, Sandoz And Stada

Executive Summary

New OTC dermatology products on the German market, including line extensions from Englehard, Medice and Stada and a 0.5% hydrocortisone cream from Sandoz.

You may also be interested in...



German OTC Marketing Round-Up, May: Stada, Pohl Boskamp, Bene And Almirall

This month’s round-up of German OTC marketing news features a line extension and a post-acquisition re-launch from Stada, a new flavor Gelo Revoice and advertising campaign for Nyda from Pohl Boskamp, a "large scale" marketing campaign for Bene's ear-care range, and Almirall's latest efforts to promote its foot-care range. 

Life’s An Itch And Then You Cry – New Hay Fever Products And Campaigns In Germany This Spring

New OTC products and campaigns for the hay fever season from: GSK, Novartis, Dermapharm, Galenpharma, DHU and Thea Pharma.

German Expert Panel Opposes OTC Ibuprofen/Phenylephrine Combo, Hydrocortisone 1%

Two prescription-to-OTC switch applications rejected by Germany’s Expert Committee for Prescription: preparations containing a combination of ibuprofen and phenylephrine hydrochloride and hydrocortisone 1% for external use.

Topics

Related Companies

Latest News
UsernamePublicRestriction

Register

RS148993

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel